← Leaderboards
Mark A. Klein
Minneapolis Va Medical Center
$0
Attributed
$0
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $0 · FY2020–25$1$1$1$0$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
VA$0 · 3
By mechanism
I01$0 · 2
I21$0 · 1
Top collaborators
- Janeen H Trembley1 shared
Most similar at Minneapolis Va Medical Center
Same institution · by research overlap
Others in their field
Other Emerging Leaders on “Basic Science”
- Leonard Freedman · Leidos Biomedical Research, Inc.$106,162,603
- Julie Ake · National Institute Of Allergy And Infectious Diseases$52,642,120
- Sujatha Rashid · American Type Culture Collection$48,624,582
- Scott Hensley · University Of Pennsylvania$47,224,291
- John Hobbs · Suny At Stony Brook$41,239,084
- Christopher Bee · Suny At Stony Brook$41,239,084
Research focus
Basic ScienceIncidenceClinical TrialsMalignant NeoplasmsCellsPharmaceutical PreparationsVeteransCancer BiologyIn VivoAsbestosInnovationGenomicsLaboratoriesFiberCyclin-Dependent Kinase InhibitorFutureClinical ResearchCombined Modality TherapyCell GrowthCarbon NanotubesFda ApprovedExposure ToAggressive TherapyCell Proliferation
Grant awards (7)
Validation of Dihydroorotate Dehydrogenase as a Therapeutic Target in Mesothelioma$0
I21 · FY2025 · VA · contact PI
Protein kinase CK2 in prostate cancer progression and clinical potential for therapy$0
I01 · FY2024 · VA
Validation of Dihydroorotate Dehydrogenase as a Therapeutic Target in Mesothelioma$0
I21 · FY2024 · VA · contact PI
Combinatorial Targeting of the Cell Cycle and Key Interacting Pathways in Mesothelioma$0
I01 · FY2023 · VA · contact PI
Combinatorial Targeting of the Cell Cycle and Key Interacting Pathways in Mesothelioma$0
I01 · FY2022 · VA · contact PI
Combinatorial Targeting of the Cell Cycle and Key Interacting Pathways in Mesothelioma$0
I01 · FY2021 · VA · contact PI
Combinatorial Targeting of the Cell Cycle and Key Interacting Pathways in Mesothelioma$0
I01 · FY2020 · VA · contact PI